Caprolactam Chemicals (BSE 507486)₹46.00−0.02%Commodity Chemicals
In the Mar 2026 quarter (standalone), Caprolactam Chemicals reported sales of ₹3.06 Cr, up 91.3% from Mar 2025, and net profit of ₹0.83 Cr. For the year to Mar 2026, sales were ₹10.55 Cr and net profit ₹1.75 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.05 | 1.96 | 1.48 | 1.43 | 1.11 | 1.70 | 2.28 | 1.60 | 2.55 | 2.35 | 2.55 | 3.06 |
| Expenses | 1.29 | 1.51 | 1.19 | 0.76 | 0.86 | 1.13 | 1.81 | 1.37 | 1.50 | 1.69 | 1.44 | 1.41 |
| Operating Profit | 0.75 | 0.44 | 0.28 | 0.66 | 0.24 | 0.56 | 0.46 | 0.22 | 1.04 | 0.67 | 1.10 | 1.64 |
| OPM % | 36.9% | 22.8% | 19.5% | 46.6% | 22.3% | 33.3% | 20.5% | 14.3% | 41.0% | 28.0% | 43.4% | 53.7% |
| Other Income | 0.16 | 0.00 | 0.00 | 0.04 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.03 | 0.00 | 0.02 |
| Interest | 0.15 | 0.14 | 0.12 | 0.13 | 0.15 | 0.15 | 0.16 | 0.19 | 0.19 | 0.20 | 0.19 | 0.18 |
| Depreciation | 0.36 | 0.38 | 0.39 | 0.41 | 0.37 | 0.39 | 0.39 | 0.40 | 0.37 | 0.38 | 0.40 | 0.43 |
| Profit before tax | 0.39 | −0.06 | −0.21 | 0.15 | −0.26 | 0.02 | −0.08 | −0.35 | 0.48 | 0.09 | 0.51 | 1.04 |
| Tax % | 25.1% | −28.5% | −31.8% | 31.3% | 0.0% | 0.0% | −66.6% | 25.1% | 24.6% | −20.0% | 17.4% | 20.1% |
| Net Profit | 0.29 | −0.05 | −0.15 | 0.11 | −0.26 | 0.03 | −0.02 | −0.44 | 0.35 | 0.12 | 0.43 | 0.83 |
| EPS (Rs) | 0.66 | −0.14 | −0.36 | 0.27 | −0.60 | 0.10 | −0.08 | −0.97 | 0.79 | 0.29 | 0.97 | 1.84 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4.87 | 3.22 | 4.06 | 5.18 | 6.50 | 6.30 | 2.06 | 9.83 | 6.95 | 6.73 | 10.55 | 10.51 |
| Expenses | 4.04 | 2.75 | 3.17 | 3.30 | 3.98 | 4.12 | 2.63 | 5.15 | 4.77 | 5.20 | 6.07 | 6.04 |
| Operating Profit | 0.82 | 0.46 | 0.88 | 1.87 | 2.51 | 2.16 | −0.56 | 4.68 | 2.16 | 1.51 | 4.46 | 4.45 |
| OPM % | 17.0% | 14.6% | 21.9% | 36.2% | 38.7% | 34.4% | −27.5% | 47.5% | 31.2% | 22.5% | 42.3% | 42.3% |
| Other Income | 0.41 | 0.02 | 0.08 | 0.08 | 0.07 | 0.10 | 0.42 | 0.03 | 0.19 | 0.02 | 0.04 | 0.05 |
| Interest | 0.12 | 0.13 | 0.20 | 0.35 | 0.31 | 0.31 | 0.27 | 0.58 | 0.51 | 0.64 | 0.73 | 0.76 |
| Depreciation | 0.50 | 0.46 | 0.56 | 0.96 | 1.01 | 1.06 | 1.02 | 1.14 | 1.57 | 1.58 | 1.60 | 1.58 |
| Profit before tax | 0.60 | −0.10 | 0.19 | 0.63 | 1.25 | 0.88 | −1.46 | 2.96 | 0.26 | −0.68 | 2.16 | 2.12 |
| Tax % | 14.8% | 0.0% | 15.0% | 23.5% | 24.6% | 27.0% | −12.9% | 14.2% | 29.7% | 4.4% | 18.5% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | 0.51 | −0.11 | 0.16 | 0.49 | 0.94 | 0.64 | −1.27 | 2.54 | 0.19 | −0.70 | 1.75 | 1.73 |
| EPS (Rs) | 1.14 | −0.27 | 0.38 | 1.10 | 2.08 | 1.42 | −2.79 | 5.53 | 0.44 | −1.53 | 3.84 | 3.89 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.60 | 4.60 | 4.60 | 4.60 | 4.61 | 4.61 | 4.61 | 4.61 | 4.61 | 4.60 | 4.61 | 4.61 |
| Reserves | −3.14 | −2.62 | −2.74 | −2.57 | −2.07 | −1.11 | −0.53 | −1.81 | 0.75 | 0.96 | 0.24 | 1.99 |
| Borrowings | 0.83 | 0.96 | 1.38 | 1.90 | 3.60 | 2.46 | 2.16 | 3.78 | 5.70 | 5.87 | 8.73 | 9.25 |
| Other Liabilities | 1.16 | 0.99 | 1.09 | 2.36 | 1.28 | 1.16 | 0.98 | 3.78 | 0.48 | 0.25 | 0.73 | 1.22 |
| Total Liabilities | 3.45 | 3.93 | 4.33 | 6.29 | 7.42 | 7.12 | 7.22 | 10.36 | 11.54 | 11.68 | 14.31 | 17.07 |
| Fixed Assets | 2.93 | 2.97 | 3.39 | 3.57 | 6.39 | 6.09 | 5.51 | 5.27 | 10.25 | 10.32 | 10.34 | 10.18 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.97 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 0.52 | 0.96 | 0.94 | 2.72 | 1.03 | 1.03 | 1.71 | 1.12 | 1.29 | 1.36 | 3.97 | 6.89 |
| Inventories | 0.18 | 0.07 | 0.26 | 0.29 | 0.08 | 0.07 | 0.10 | 0.11 | 0.08 | 0.06 | 0.40 | 0.15 |
| Trade receivables | 0.00 | 0.53 | 0.35 | 0.78 | 0.03 | 0.29 | 0.48 | 0.02 | 0.67 | 0.63 | 2.81 | 6.20 |
| Cash & equivalents | 0.12 | 0.17 | 0.12 | 0.80 | 0.33 | 0.35 | 0.53 | 0.16 | 0.24 | 0.10 | 0.09 | 0.10 |
| Total Assets | 3.45 | 3.93 | 4.33 | 6.29 | 7.42 | 7.12 | 7.22 | 10.36 | 11.54 | 11.68 | 14.31 | 17.07 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 1.45 | 0.59 | 0.55 | 1.11 | 2.97 | 2.19 | 1.26 | 3.06 | 0.87 | 1.83 | −0.63 | 1.66 |
| Cash from investing activity | −2.17 | −0.57 | −0.90 | −0.76 | −3.79 | −0.74 | −0.49 | −4.76 | −2.15 | −1.65 | −1.61 | −1.42 |
| Cash from financing activity | 0.69 | 0.03 | 0.31 | 0.34 | 0.36 | −1.44 | −0.60 | 1.34 | 1.38 | −0.33 | 2.23 | −0.24 |
| Net cash flow | −0.06 | 0.06 | −0.06 | 0.69 | −0.48 | 0.03 | 0.19 | −0.38 | 0.09 | −0.15 | 0.00 | 0.00 |
| Capex | 2.15 | 0.57 | 0.88 | 0.77 | 3.79 | 0.72 | 0.50 | 4.76 | 2.17 | 1.66 | 1.62 | 1.48 |
| Free cash flow | −0.71 | 0.01 | −0.34 | 0.33 | −0.81 | 1.44 | 0.75 | −1.69 | −1.29 | 0.16 | −2.22 | 0.21 |
| CFO / OP % | 369.0% | 82.0% | 115.0% | 128.0% | 164.0% | 92.0% | 79.9% | −591.1% | 27.0% | 88.0% | −41.0% | 39.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 0 | 38 | 40 | 68 | 2 | 16 | 26 | 4 | 24 | 33 | 152 | 214 |
| Inventory days | — | — | — | 304 | 89 | — | — | 83 | 54 | 52 | 112 | 66 |
| Days payable | — | — | — | 863 | 800 | — | — | 345 | 175 | 113 | 121 | 213 |
| Cash conversion cycle | 1 | 39 | 41 | −489 | −707 | 17 | 27 | −256 | −94 | −26 | 145 | 69 |
| Working capital days | −190 | −72 | −170 | −232 | −274 | −158 | −106 | −689 | −94 | −267 | −315 | −134 |
| ROCE % | 11.3% | 27.6% | 0.3% | 10.9% | 19.5% | 25.9% | 19.5% | −18.6% | 40.2% | 6.9% | −0.5% | 19.7% |
For the Mar 2026 quarter, Caprolactam Chemicals reported sales of ₹3.06 Cr, up 91.3% year on year and net profit of ₹0.83 Cr. The operating margin was 53.7%.
Caprolactam Chemicals' sales for the year to Mar 2026 were ₹10.55 Cr; over the last twelve months they were ₹10.51 Cr.
Net profit for the year to Mar 2026 was ₹1.75 Cr, and ₹1.73 Cr over the last twelve months. Earnings per share over the same trailing period were ₹3.89.
Caprolactam Chemicals reported borrowings of ₹9.25 Cr at Mar 2026, against cash and equivalents of ₹0.10 Cr.
Cash from operations was ₹1.66 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹0.21 Cr.